BMJ Best Practice

参考文献

关键文献

Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137.

Boyer CB, Shafer MB, Pollack LM, et al. Sociodemographic markers and behavioral correlates of STIs in a nonclinical sample of adolescent and young adult women. J Infect Dis. 2006 Aug 1;194(3):307-15.

Marrazzo JM, Weisenfeld HC, Murray PJ, et al. Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis. 2006 Mar 1;193(5):617-24.

Scholes D, Grothaus L, McClure J, et al. A randomized trial of strategies to increase Chlamydia screening in young women. Prev Med. 2006 Oct;43(4):343-50.

Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002 Sep;29(9):497-502.

参考文章

1.  Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137.

2.  Boyer CB, Shafer MB, Pollack LM, et al. Sociodemographic markers and behavioral correlates of STIs in a nonclinical sample of adolescent and young adult women. J Infect Dis. 2006 Aug 1;194(3):307-15.

3.  Crofts M, Horner P. Chlamydia (uncomplicated, genital). BMJ Clin Evid. April 2015 [internet publication].

4.  Centers for Disease Control and Prevention. 2016 sexually transmitted diseases surveillance. September 2017 [internet publication].

5.  Creighton S. Gonorrhoea. BMJ Clin Evid. February 2014 [internet publication].

6.  Blanchard A, Bébéar C. The evolution of Mycoplasma genitalium. Ann N Y Acad Sci. 2011 Aug;1230:E61-4.

7.  Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am J Obstet Gynecol. 2012 Jun;206(6):476;e1-8.

8.  Marrazzo JM, Martin DH. Management of women with cervicitis. Clin Infect Dis. 2007 Apr 1;44(suppl 3):S102-10.

9.  Groetsch S. Cervicitis. Clin Fam Pract. 2005;7:43-56.

10.  Geisler WM, Suchland RJ, Whittington WL, et al. Quantitative culture of Chlamydia trachomatis: a relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. J Infect Dis. 2001;184:1350-1354.

11.  Marrazzo JM, Weisenfeld HC, Murray PJ, et al. Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis. 2006 Mar 1;193(5):617-24.

12.  Newman LM, Warner L, Weinstock HS. Predicting subsequent infection in patients attending sexually transmitted disease clinics. Sex Transm Dis. 2006 Dec;33(12):737-42.

13.  Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003 Mar 1;36(5):663-8.

14.  Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996 May 23;334(21):1362-6.

15.  Scholes D, Grothaus L, McClure J, et al. A randomized trial of strategies to increase Chlamydia screening in young women. Prev Med. 2006 Oct;43(4):343-50.

16.  Hakakha MM, Davis J, Korst LM, et al. Leukorrhea and bacterial vaginosis as in-office predictors of cervical infection in high risk women. Obstet Gynecol. 2002 Oct;100(4):808-12.

17.  Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991 Feb;29(2):297-301.

18.  Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983 Jan;74(1):14-22.

19.  Crotchfelt KA, Pare B, Gaydos C, et al. Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia trachomatis assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol. 1998 Feb;36(2):391-4.

20.  Schoeman SA, Stewart CM, Booth RA, et al. Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study. BMJ. 2012 Dec 12;345:e8013.

21.  Centers for Disease Control and Prevention. National estimate shows not enough young women tested for chlamydia (press release). March 2012 [internet publication].

22.  Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):590-4.

23.  Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002 Sep;29(9):497-502.

24.  Oh MK, Cloud, GA, Fleenor, M, et al. Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study. J Adolesc Health. 1996;18:270-275.

25.  Wiesenfeld HC, Hillier SL, Meyn LA, et al. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol. 2012;120:37-43.

26.  Yang K, Li J, Liu Y, et al. Microwave therapy for cervical ectropion. Cochrane Database Syst Rev. 2007;(4):CD006227.

使用此内容应接受我们的免责声明